Argus Research analyst Taylor Conrad downgrades Bath & Body Works (NYSE:BBWI) from Buy to Hold.
Watching Provention Bio; Shares Move Lower As Co Showcases Webinar Titled ‘Tzield: Learn More About A Newly Approved Therapy’
https://members.amcp.org/AMCP2019/Events/Event_Display.aspx?EventKey=GTW_230118&WebsiteKey=2bfc55cc-0861-4d8b-91d1-9a8c0f748666